TORIPALIMAB
Manner of administration:Injection
Restriction (Streamlined authority code: 17616)
Indication: Recurrent or metastatic nasopharyngeal carcinoma
Quantities & Cost
| Max amount | # of repeats | DPMA | Max safety net | General Patient Charge |
|---|---|---|---|---|
| Max amount: 240 mg | # of repeats: 7 | DPMA: $9,548.26 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | ||||
| Zytorvi
(Toripalimab 240 mg/6 mL injection, 6 mL vial)
|
||||
Manner of administration:Injection
Restriction (Streamlined authority code: 17616)
Indication: Recurrent or metastatic nasopharyngeal carcinoma
Quantities & Cost
| Max amount | # of repeats | DPMA | Max safety net | General Patient Charge |
|---|---|---|---|---|
| Max amount: 240 mg | # of repeats: 7 | DPMA: $9,726.33 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | ||||
| Zytorvi
(Toripalimab 240 mg/6 mL injection, 6 mL vial)
|
||||
